IL17A and lupus nephritis: For example, secukinumab, anti-IL-17A antibody, was tested in relapsing multiple sclerosis patients (NCT01874340) and has been tested in psoriatic arthritis (NCT04711902) or lupus nephritis (NCT04181762).